INBX
Price
$34.74
Change
+$0.05 (+0.14%)
Updated
May 10, 9:17 AM EST
87 days until earnings call
SNTI
Price
$0.37
Change
-$0.00 (-0.00%)
Updated
May 10, 9:12 AM EST
Ad is loading...

INBX vs SNTI

Header iconINBX vs SNTI Comparison
Open Charts INBX vs SNTIBanner chart's image
Inhibrx
Price$34.74
Change+$0.05 (+0.14%)
Volume$100
CapitalizationN/A
Senti Biosciences
Price$0.37
Change-$0.00 (-0.00%)
Volume$2.55K
CapitalizationN/A
View a ticker or compare two or three
INBX vs SNTI Comparison Chart

Loading...

INBXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNTIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
INBX vs. SNTI commentary
May 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a Buy and SNTI is a Hold.

COMPARISON
Comparison
May 10, 2024
Stock price -- (INBX: $34.70 vs. SNTI: $0.37)
Brand notoriety: INBX and SNTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 201% vs. SNTI: 31%
Market capitalization -- INBX: $1.63B vs. SNTI: $16.93M
INBX [@Biotechnology] is valued at $1.63B. SNTI’s [@Biotechnology] market capitalization is $16.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $567.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 0 FA rating(s) are green whileSNTI’s FA Score has 1 green FA rating(s).

  • INBX’s FA Score: 0 green, 5 red.
  • SNTI’s FA Score: 1 green, 4 red.
According to our system of comparison, SNTI is a better buy in the long-term than INBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 4 TA indicator(s) are bullish while SNTI’s TA Score has 4 bullish TA indicator(s).

  • INBX’s TA Score: 4 bullish, 4 bearish.
  • SNTI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both INBX and SNTI are a good buy in the short-term.

Price Growth

INBX (@Biotechnology) experienced а +2.03% price change this week, while SNTI (@Biotechnology) price change was +0.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.16%. For the same industry, the average monthly price growth was -4.80%, and the average quarterly price growth was +70.58%.

Reported Earning Dates

INBX is expected to report earnings on Aug 05, 2024.

SNTI is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+0.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for INBX with price predictions.
OPEN
A.I.dvisor published
a Summary for SNTI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
INBX($1.63B) has a higher market cap than SNTI($16.9M). INBX YTD gains are higher at: -8.684 vs. SNTI (-43.939).
INBXSNTIINBX / SNTI
Capitalization1.63B16.9M9,657%
EBITDAN/AN/A-
Gain YTD-8.684-43.93920%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
INBXSNTI
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
INBXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNTIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VICCX20.310.25
+1.25%
USA Mutuals Vice C
NAMAX14.120.16
+1.15%
Columbia Select Mid Cap Value Instl
VAAGX27.020.29
+1.08%
Virtus NFJ Large-Cap Value R6
CSHZX10.410.09
+0.87%
MainStay Cushing® MLP Premier I
JVMRX29.120.25
+0.87%
JHancock Disciplined Value Mid Cap R6

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+0.75%
AXON - INBX
48%
Loosely correlated
-0.94%
AKRO - INBX
44%
Loosely correlated
-1.05%
SNTI - INBX
39%
Loosely correlated
-7.43%
KYMR - INBX
39%
Loosely correlated
+0.29%
RAPT - INBX
38%
Loosely correlated
-41.73%
More

SNTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNTI has been loosely correlated with INBX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SNTI jumps, then INBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNTI
1D Price
Change %
SNTI100%
-7.43%
INBX - SNTI
41%
Loosely correlated
+0.75%
NVIVQ - SNTI
34%
Loosely correlated
-5.00%
CUE - SNTI
30%
Poorly correlated
+0.52%
BMRN - SNTI
30%
Poorly correlated
-0.13%
NRXP - SNTI
28%
Poorly correlated
+3.90%
More